Stock & Company Details
GT Biopharma Inc $GTBP
Price:
N/A
N/A
1.8M
$14M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.70
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GTBP technical indicators
Latest GT Biopharma Inc (GTBP) indicator readings as of 2026-09-18.
GTBP's 14-day RSI is 65.6, in neutral territory. At $7.16 it is trading 803.2% above its 200-day moving average of $0.79, and above its 50-day average of $1.64. Price sits in the middle of its Bollinger Bands ($-4.14 to $11.36). ADX reads 55.1, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
Finance Bot
Ask your questions
Start by typing a question below.
